uz
Feedback
Respiratory Updates

Respiratory Updates

Kanalga Telegram’da o‘tish

🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Ko'proq ko'rsatish

📈 Telegram kanali Respiratory Updates analitikasi

Respiratory Updates (@respiratoryupdates) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 19 459 obunachidan iborat bo'lib, Tibbiyot toifasida 1 177-o'rinni va Eron mintaqasida 17 223-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 19 459 obunachiga ega bo‘ldi.

28 Avgust, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 462 ga, so‘nggi 24 soatda esa 25 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 15.90% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 5.50% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 3 091 marta ko‘riladi; birinchi sutkada odatda 1 070 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 4 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent patient, guideline, edit, reader, society kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Yuqori yangilanish chastotasi (oxirgi ma’lumot 29 Avgust, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

19 459
Obunachilar
+2524 soatlar
+1117 kunlar
+46230 kunlar
Obunachilarni jalb qilish
Avgust '26
Avgust '26
+480
1 kanalda
Iyul '26
+584
0 kanalda
Get PRO
Iyun '26
+565
0 kanalda
Get PRO
May '26
+718
0 kanalda
Get PRO
Aprel '26
+515
0 kanalda
Get PRO
Mart '26
+196
0 kanalda
Get PRO
Fevral '26
+185
0 kanalda
Get PRO
Yanvar '26
+238
1 kanalda
Get PRO
Dekabr '25
+234
0 kanalda
Get PRO
Noyabr '25
+286
2 kanalda
Get PRO
Oktabr '25
+335
0 kanalda
Get PRO
Sentabr '25
+408
0 kanalda
Get PRO
Avgust '25
+389
1 kanalda
Get PRO
Iyul '25
+429
0 kanalda
Get PRO
Iyun '25
+420
4 kanalda
Get PRO
May '25
+416
0 kanalda
Get PRO
Aprel '25
+457
1 kanalda
Get PRO
Mart '25
+496
1 kanalda
Get PRO
Fevral '25
+548
1 kanalda
Get PRO
Yanvar '25
+981
1 kanalda
Get PRO
Dekabr '24
+1 335
1 kanalda
Get PRO
Noyabr '24
+1 714
2 kanalda
Get PRO
Oktabr '24
+1 758
1 kanalda
Get PRO
Sentabr '24
+1 250
1 kanalda
Get PRO
Avgust '24
+1 052
2 kanalda
Get PRO
Iyul '24
+418
5 kanalda
Get PRO
Iyun '24
+520
3 kanalda
Get PRO
May '24
+368
2 kanalda
Get PRO
Aprel '24
+365
2 kanalda
Get PRO
Mart '24
+385
2 kanalda
Get PRO
Fevral '24
+437
2 kanalda
Get PRO
Yanvar '24
+704
3 kanalda
Get PRO
Dekabr '23
+683
1 kanalda
Sana
Obunachilarni jalb qilish
Esdaliklar
Kanallar
29 Avgust+20
28 Avgust+25
27 Avgust+13
26 Avgust+14
25 Avgust+12
24 Avgust+19
23 Avgust+15
22 Avgust+13
21 Avgust+16
20 Avgust+22
19 Avgust+17
18 Avgust+12
17 Avgust+19
16 Avgust+17
15 Avgust+21
14 Avgust+15
13 Avgust+12
12 Avgust+25
11 Avgust+34
10 Avgust+10
09 Avgust+14
08 Avgust+5
07 Avgust+14
06 Avgust+14
05 Avgust+17
04 Avgust+18
03 Avgust+17
02 Avgust+18
01 Avgust+12
Kanal postlari
+1
🔴 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement

2
IDSA_Treatment_of_Antimicrobial_Resistant_Gram_Negative_Infections.pdf
2 267
3
SARCOIDOSIS: Edited by Vasileios Kouranos and Maneesh Bhargava Recent updates in advanced pulmonary sarcoidosis Current Opinion in Pulmonary Medicine 32(5):p 491-499, September 2026. | DOI: 10.1097/MCP.0000000000001295
4 805
4
Respiratory Medicine Volume 255, April–May 2026, 108751 Original Research The effect of the CareAide® mobile application in adult outpatients with asthma: A randomised controlled trial https://doi.org/10.1016/j.rmed.2026.108751
4 230
5
Navigating evidence-based recommendations for the management of systemic sclerosis. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01416-z
4 325
6
Review Article Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials the Nebulized Heparin Study Group Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161
4 540
7
Annals of intensive care.pdf
4 698
8
American Journal of Kidney Diseases Available online 3 July 2026 In Press, Journal Pre-proof Perspective Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies https://doi.org/10.1053/j.ajkd.2026.03.048
4 761
9
ICU Nutrition Q&A.pdf
4 805
10
خلاصه وازوپرسو و اینوتروپ #Critical_Care
خلاصه وازوپرسو و اینوتروپ #Critical_Care
5 038
11
آقای ۶۲ ساله با تشخیص شوک سپتیک ناشی از پنومونی، در icu . بیمار تحت رژیم درمانی با نوراپی‌نفرین ۳۶ میکروگرم در دقیقه قرار دارد. در آخرین بررسی: · MAP = ۵۵ U/O = ۰.۳ cc/kh/ht · لاکتات سرم = ۴.۲ (روند نزولی ندارد) · CRT = ۴ بهترین اقدام؟
1
12
Feature Article Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis Critical Care Medicine 54(6):p 1293-1308, June 2026. | DOI: 10.1097/CCM.0000000000007072
5 705
13
+2
The Lancet Respiratory Medicine Available online 5 June 2026 In Press, Corrected Proof Position Paper Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement https://doi.org/10.1016/S2213-2600(26)00094-9
6 903
14
Critical_Care_2025 مبادرة خير.pdf
6 369
15
+1
Matn yo'q...
3 364
16
+1
Matn yo'q...
3 330
17
The new ACC/AHA 2026 guidelines of pulmonary embolism
3 276
18
creager_et_al_2026_2026_aha_acc_accp_acep_chest_sc_260219_225656.pdf
4 146
19
Matn yo'q...
5 051
20
The Lancet Respiratory Medicine Available online 12 February 2026 In Press, Corrected Proof Articles Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials KALOS and LOGOS study investigators † https://doi.org/10.1016/S2213-2600(25)00457-6
5 027